Bank Of New York Mellon Corp Grifols Sa Call Options Transaction History
Bank Of New York Mellon Corp
- $541 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GRFS
# of Institutions
170Shares Held
146MCall Options Held
166KPut Options Held
103K-
Capital World Investors Los Angeles, CA21.1MShares$150 Million0.02% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA20.5MShares$145 Million1.82% of portfolio
-
Permian Investment Partners, LP New York, NY16.2MShares$115 Million21.69% of portfolio
-
Black Creek Investment Management Inc. Toronto, A611.3MShares$79.7 Million3.99% of portfolio
-
Armistice Capital, LLC New York, NY10MShares$71.1 Million1.05% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $4.81B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...